反応式
[H-].[Na+].[CH2:3]([C:5]1[NH:6][C:7]2[CH2:8][CH2:9][CH2:10][CH2:11][C:12]=2[C:13](=[O:15])[CH:14]=1)[CH3:4].[H][H].Br[CH2:19][C:20]1[CH:38]=[CH:37][C:23]([O:24][C:25]2[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=2[CH2:31][C:32]([O:34][CH2:35][CH3:36])=[O:33])=[CH:22][CH:21]=1>CN(C=O)C.O>[CH2:3]([C:5]1[CH:14]=[C:13]([O:15][CH2:19][C:20]2[CH:38]=[CH:37][C:23]([O:24][C:25]3[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=3[CH2:31][C:32]([O:34][CH2:35][CH3:36])=[O:33])=[CH:22][CH:21]=2)[C:12]2[CH2:11][CH2:10][CH2:9][CH2:8][C:7]=2[N:6]=1)[CH3:4]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
Sodium hydride (60% dispersion in mineral oil; 63 mg) was added to a solution of compound D (254 mg) in DMF (5 ml). When evolution of hydrogen ceased, a solution of compound C (500 mg) in DMF (5 ml) was added and the solution was left to stand for 20 hours. Water (50 ml) was added and the mixture was extracted with ethyl acetate (2×25 ml). The combined extracts were washed with water (25 ml), followed by saturated sodium chloride solution (25 ml) and then dried (MgSO4). The solvent was removed by evaporation and the residue purified by flash chromatography, eluting with ethyl acetate/hexane (1:1 v/v), to give ethyl 2-[4-((2-ethyl-5,6,7,8-tetrahydroquinolin-4-yl)oxymethyl)phenoxy]phenylacetate (A) (265 mg), as an oil which solidified on standing, m.p. 89°-90° C. (after trituration with hexane); NMR: 1.1-1.35(2×t, 6H), 1.7-1.9(m, 4H), 2.6(t, 2H), 2.7(q, 2H), 2.85(t, 2H), 4.1-4.3(m, 2H), 5.0(s, 2H), 5.6(s, 1H), 6.5(s, 1H), 7.0(d, 2H), 7.25-7.5(m, 5H), 7.55-7.65(m, 2H).
後処理
- waitthe solution was left
- extractionthe mixture was extracted with ethyl acetate (2×25 ml)
- washThe combined extracts were washed with water (25 ml)
- dry with materialdried (MgSO4)
- customThe solvent was removed by evaporation
- customthe residue purified by flash chromatography
- washeluting with ethyl acetate/hexane (1:1 v/v)
出典と根拠
- ORDレコード
- ord-411f1f1d6b3446cebf4f363d6c1ce3de
- 出典データセット
- uspto-grants-1994_12
- 特許番号
- US05373015
関連ノート
読み込み中…